What we do
The Medical Delta Imaging Institute (MDII) focuses on developing innovative imaging-based technologies for diagnostics, prognostics and the assessment of treatment of patients suffering from cardiovascular and neurovascular diseases.
MDII will validate how effectively these techniques improve public health, and will translate them into commercially viable solutions for clinical practice.
In terms of directions for research, our focus is on developing preventative measures that can be implemented in people’s homes, and treatments that are targeted and precise. In short, we want people to be able to take control of their own health so that they live healthier, more active and longer lives.
The Medical Delta Imaging Institute (MDII) will create focus and mass in cardio- and neurovascular medical device development. The Mission of MDII is to reduce morbidity and mortality associated with cardiovascular and neurodegenerative diseases.
It is MDII’s vision that imaging technology can help decreasing healthcare costs associated with diseases by: developing early and specific diagnostic tools that allow for a shift from treatment to prevention; developing prognostic tools that allow for personalized prognosis and a tailor-made therapeutic strategy; developing tools to assess the treatment efficacy in an early phase, allowing for faster installment of an optimal (personalized) therapy.
To reduce morbidity and mortality associated with cardiovascular and neurodegenerative diseases, the following advances are required:
- improved (early and differential) diagnosis
- improved (personalized) prognosis
- improved (personalized) treatment planning and monitoring
Synergistic improvements in medical image acquisition technology and subsequent analysis are essential to achieve these advances.
MDII will implement these technologies in the context of large epidemiological and clinical studies to derive novel imaging biomarkers of cardio- and neurovascular disease. Moreover, it will valorize validated techniques through industries in medical imaging and pharmaceuticals.